Guided Therapeutics (GTHP) Preferred Dividend Payments (2013 - 2026)
Guided Therapeutics (GTHP) posted Preferred Dividend Payments of $24000.0 for Q4 2025, down 44.19% sequentially from $43000.0 in Q3 2025, and down 50.0% YoY from $48000.0 in Q4 2024.
Guided Therapeutics (GTHP) Preferred Dividend Payments (2013 - 2026) Analysis & Trends
Guided Therapeutics has reported Preferred Dividend Payments for 13 years, with the latest figure at $24000.0 in Q4 2025.
- Quarterly Preferred Dividend Payments fell 50.0% year-over-year to $24000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $148000.0 (down 14.94% YoY) and the FY2025 annual result came in at $150000.0, down 13.79% from the prior year.
- Preferred Dividend Payments eased to $24000.0 in Q4 2025 per GTHP's latest filing, from $43000.0 in the prior quarter.
- Over five years, Preferred Dividend Payments peaked at $548000.0 in Q1 2022 and troughed at -$55000.0 in Q1 2021.
- A 5-year average of $73700.0 and a median of $47500.0 in 2022 frame the typical range for Preferred Dividend Payments.
- The sharpest annual moves came in 2021 and 2022: Preferred Dividend Payments tumbled 558.33% in 2021, then jumped 1096.36% in 2022.
- Over 5 years, Preferred Dividend Payments stood at $65000.0 in 2021, then retreated by 23.08% to $50000.0 in 2022, then slipped by 2.0% to $49000.0 in 2023, then fell by 2.04% to $48000.0 in 2024, then slumped by 50.0% to $24000.0 in 2025.
- According to Business Quant data, Preferred Dividend Payments over the past three periods registered $24000.0, $43000.0, and $45000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | - |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | - |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | - |
| 10 | Guided Therapeutics | 26.06 Mn | 26.05 Mn | - | -1,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1,000.00 |
| Dec 31, 2025 | 24,000.00 |
| Sep 30, 2025 | 43,000.00 |
| Jun 30, 2025 | 45,000.00 |
| Mar 31, 2025 | 36,000.00 |
| Dec 31, 2024 | 48,000.00 |
| Sep 30, 2024 | 38,000.00 |
| Jun 30, 2024 | 49,000.00 |
| Mar 31, 2024 | 39,000.00 |
| Dec 31, 2023 | 49,000.00 |
| Sep 30, 2023 | 40,000.00 |
| Jun 30, 2023 | 47,000.00 |
| Mar 31, 2023 | 35,000.00 |
| Dec 31, 2022 | 50,000.00 |
| Sep 30, 2022 | 48,000.00 |
| Jun 30, 2022 | 81,000.00 |
| Mar 31, 2022 | 548,000.00 |
| Dec 31, 2021 | 65,000.00 |
| Sep 30, 2021 | 119,000.00 |
| Jun 30, 2021 | 125,000.00 |